Literature DB >> 1623799

Nontuberculous mycobacteria in adult patients with cystic fibrosis.

J M Kilby1, P H Gilligan, J R Yankaskas, W E Highsmith, L J Edwards, M R Knowles.   

Abstract

Because patients with cystic fibrosis (CF) may be predisposed to airway infections with unusual microorganisms, we screened the sputum of adult CF patients for mycobacterial organisms. Acid-fast bacilli (AFB) smears and mycobacterial culture were performed on 297 sputum specimens from 87 patients. Cultures for mycobacteria were frequently overgrown with other bacteria; 22.6 percent of cultures were contaminated. Despite this limitation of mycobacterial culture, 17 patients had at least one positive culture for a Mycobacterium other than tuberculosis (MOTT). Eleven patients were positive for Mycobacterium avium-intracellulare (MAI), two for MAI and M chelonei, three for M chelonei, and one for M fortuitum. None was positive for M tuberculosis. Patients with CF with MOTT were similar to patients with CF without MOTT; only a slightly different (older) age distribution was recognized. The clinical significance of MOTT was difficult to determine in any individual patient, but patients with positive AFB smears appeared more likely to suffer pathogenic effects. We conclude that MOTT is frequently recovered from adult CF patients in the southeastern United States. A specific risk factor for colonization and/or pathogenic infection in this patient group was not evident. The general prevalence and clinical pathogenesis in CF patients in the United States remains to be determined.

Entities:  

Mesh:

Year:  1992        PMID: 1623799     DOI: 10.1378/chest.102.1.70

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  42 in total

Review 1.  Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis.

Authors:  Melissa B Miller; Peter H Gilligan
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

Review 2.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

3.  Value of the chlorhexidine decontamination method for recovery of nontuberculous mycobacteria from sputum samples of patients with cystic fibrosis.

Authors:  Agnès Ferroni; Hoang Vu-Thien; Philippe Lanotte; Muriel Le Bourgeois; Isabelle Sermet-Gaudelus; Brigitte Fauroux; Sophie Marchand; Françoise Varaigne; Patrick Berche; Jean-Louis Gaillard; Catherine Offredo
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

4.  Proficiency testing of clinical microbiology laboratories using modified decontamination procedures for detection of nontuberculous mycobacteria in sputum samples from cystic fibrosis patients. The Nontuberculous Mycobacteria in Cystic Fibrosis Study Group.

Authors:  S Whittier; K Olivier; P Gilligan; M Knowles; P Della-Latta
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

5.  Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis.

Authors:  Stacey L Martiniano; Marci K Sontag; Charles L Daley; Jerry A Nick; Scott D Sagel
Journal:  Ann Am Thorac Soc       Date:  2014-01

6.  Use of specific rRNA oligonucleotide probes for microscopic detection of Mycobacterium avium complex organisms in tissue.

Authors:  Allison L St Amand; Daniel N Frank; Mary Ann De Groote; Norman R Pace
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

Review 7.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 8.  Epidemiology of infection by nontuberculous mycobacteria.

Authors:  J O Falkinham
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

9.  Sampling and decontamination method for culture of nontuberculous mycobacteria in respiratory samples of cystic fibrosis patients.

Authors:  Annelies De Bel; Deborah De Geyter; Iris De Schutter; Christine Mouton; Isabelle Wellemans; Laurence Hanssens; Petra Schelstraete; Anne Malfroot; Denis Pierard
Journal:  J Clin Microbiol       Date:  2013-09-18       Impact factor: 5.948

Review 10.  Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis.

Authors:  Janice M Leung; Kenneth N Olivier
Journal:  Curr Opin Pulm Med       Date:  2013-11       Impact factor: 3.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.